Brand name
Minipress itself isn’t sold as a prescription anymore.
Generic name: prazosin
Used for: High blood pressure
From
$8.98 for 30 capsules
Generic prazosin at Walgreens with the free Optum Perks coupon. Pick the strength on your label for its own price.
Rather have it mailed? From $11 for 30 capsules from Rx Outreach, by mail. Make a free account, then have your prescription sent there.
Open Rx OutreachA regular generic has the same active ingredient as Minipress, and the FDA requires it to work the same way.
Minipress itself isn’t sold as a prescription anymore.
The same medicine as Minipress, without the brand name
The same medicine as Minipress, without the brand name. Its NDC is the number that names the exact product: give it to the pharmacy and they can look it up or order it.
prazosin
Pick your strength
Give the pharmacy this NDC
What to say at the pharmacy
“Before you fill my Minipress, can you tell me what I’d pay for the brand, for the authorized generic from Prasco Laboratories (NDC ), and for a regular generic?”
Paying cash? Ask for each one’s cash price. With insurance, ask what your plan charges for each.
Source: FDA, updated November 16, 2026
Official labels and ingredient lists from DailyMed (U.S. National Library of Medicine).
1 mg capsule
Minipress itself isn’t sold anymore, so there’s no current brand label to compare. Here’s the authorized generic’s label.
Active: prazosin hydrochloride 1 mg
Inactive:
2 mg capsule
Minipress itself isn’t sold anymore, so there’s no current brand label to compare. Here’s the authorized generic’s label.
Active: prazosin hydrochloride 2 mg
Inactive:
5 mg capsule
Minipress itself isn’t sold anymore, so there’s no current brand label to compare. Here’s the authorized generic’s label.
Active: prazosin hydrochloride 5 mg
Inactive:
Same active ingredient as Minipress. Fillers and dyes can differ.
Pharmacies’ own cash prices for generic prazosin, lowest first.
Pick up in storeDelivered
From each pharmacy’s own site, read November 17, 2026. Confirm the price before you fill.
Prices change, can differ by store and state, and may depend on the strength and how many you take. With insurance, ask what your plan charges; it can be less.
10 companies sell a generic of Minipress that the FDA rates a substitute. A pharmacy fills whichever one it stocks. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.
Has dyes: FD&C Blue No. 1, FD&C Red No. 3
1 mg Opaque white cap and opaque white body, capsule, 14 mm, marked “A / 320”
| Package | NDC |
|---|---|
| Bottle of 100 | 62332-691-31 |
| Bottle of 250 | 62332-691-61 |
| Bottle of 1000 | 62332-691-91 |
2 mg Opaque pink cap and opaque white body, capsule, 18 mm, marked “A / 321”
| Package | NDC |
|---|---|
| Bottle of 100 | 62332-692-31 |
| Bottle of 250 | 62332-692-61 |
| Bottle of 1000 | 62332-692-91 |
5 mg Opaque blue cap and opaque white body, capsule, 21 mm, marked “A / 322”
| Package | NDC |
|---|---|
| Bottle of 100 | 62332-693-31 |
| Bottle of 250 | 62332-693-61 |
| Bottle of 1000 | 62332-693-91 |
Inactive ingredients: sucrose, starch, corn, sodium lauryl sulfate, microcrystalline cellulose, silicon dioxide, magnesium stearate, gelatin, titanium dioxide, shellac, potassium hydroxide, ferrosoferric oxide, FD&C Blue No. 1, FD&C Red No. 3
Has lactose · Has dyes: D&C Yellow No. 10, FD&C Green No. 3, D&C Red No. 28, FD&C Blue No. 1, FD&C Red No. 40 · Made by Novitium Pharma
Product page on anipharmaceuticals.com
1 mg Dark green colored cap and Light brown colored body, capsule, 18 mm, marked “019 / novitium”
| Package | NDC |
|---|---|
| Bottle of 90 | 70954-019-50 |
| Bottle of 100 | 70954-019-10 |
| Carton of 100 | 70954-019-40 |
| Bottle of 1000 | 70954-019-20 |
2 mg Brown colored cap and Light brown colored body, capsule, 18 mm, marked “020 / novitium”
| Package | NDC |
|---|---|
| Bottle of 100 | 70954-020-10 |
| Carton of 100 | 70954-020-40 |
| Bottle of 1000 | 70954-020-20 |
5 mg Light blue colored cap and Light brown colored body, capsule, 22 mm, marked “021 / novitium”
| Package | NDC |
|---|---|
| Bottle of 100 | 70954-021-10 |
| Carton of 100 | 70954-021-40 |
| Bottle of 250 | 70954-021-20 |
Inactive ingredients: silicon dioxide, anhydrous lactose, lactose monohydrate, magnesium stearate, cellulose, microcrystalline, ferrosoferric oxide, gelatin, ferric oxide red, titanium dioxide, ferric oxide yellow, D&C Yellow No. 10, FD&C Green No. 3, D&C Red No. 28, FD&C Blue No. 1, FD&C Red No. 40
Has dyes: D&C Yellow No. 10, FD&C Yellow No. 6, FD&C Blue No. 1, FD&C Red No. 3
1 mg Yellow opaque cap and yellow opaque body, capsule, 14 mm, marked “PRA / 1”
| Package | NDC |
|---|---|
| Bottle of 100 | 59651-271-01 |
| Bottle of 1000 | 59651-271-99 |
2 mg Yellow opaque cap and pink opaque body, capsule, 18 mm, marked “PRA / 2”
| Package | NDC |
|---|---|
| Bottle of 100 | 59651-272-01 |
| Bottle of 1000 | 59651-272-99 |
5 mg Yellow opaque cap and blue opaque body, capsule, 22 mm, marked “PRA / 5”
| Package | NDC |
|---|---|
| Bottle of 100 | 59651-273-01 |
| Bottle of 250 | 59651-273-25 |
Inactive ingredients: starch, corn, magnesium stearate, sodium lauryl sulfate, sucrose, gelatin, titanium dioxide, D&C Yellow No. 10, FD&C Yellow No. 6, ferrosoferric oxide, potassium hydroxide, shellac, FD&C Blue No. 1, FD&C Red No. 3
Has dyes: D&C Red No. 28, FD&C Blue No. 1, FD&C Red No. 40 · Made by Appco Pharma
1 mg WHITE OPAQUE BODY WHITE OPAQUE CAP, capsule, 17 mm, marked “AC / 540”
| Package | NDC |
|---|---|
| Bottle of 100 | 70377-066-11 |
2 mg WHITE OPAQUE BODY AND PINK OPAQUE CAP, capsule, 17 mm, marked “AC / 541”
| Package | NDC |
|---|---|
| Bottle of 100 | 70377-067-11 |
5 mg PINK OPAQUE BODY AND PINK OPAQUE CAP, capsule, 21 mm, marked “AC / 542”
| Package | NDC |
|---|---|
| Bottle of 100 | 70377-068-11 |
Inactive ingredients: silicon dioxide, magnesium stearate, sodium starch glycolate type a potato, sucrose, gelatin, titanium dioxide, ferrosoferric oxide, potassium hydroxide, propylene glycol, shellac, FD&C Blue No. 1, FD&C Red No. 40, D&C Red No. 28
Has lactose · Has dyes: FD&C Blue No. 1, FD&C Red No. 3, FD&C Red No. 40 · Made by Granules Pharmaceuticals
1 mg White opaque cap and white opaque body, capsule, 18 mm, marked “GPI / 1mg / 084”
| Package | NDC |
|---|---|
| Bottle of 100 | 76282-721-01 |
| Bottle of 1000 | 76282-721-10 |
2 mg Pink opaque cap and white opaque body, capsule, 18 mm, marked “GPI / 2mg / 085”
| Package | NDC |
|---|---|
| Bottle of 100 | 76282-722-01 |
| Bottle of 1000 | 76282-722-10 |
5 mg DARK BLUE OPAQUE CAP AND WHITE OPAQUE BODY, capsule, 22 mm, marked “GPI / 5mg / 086”
| Package | NDC |
|---|---|
| Bottle of 100 | 76282-723-01 |
| Bottle of 250 | 76282-723-25 |
Inactive ingredients: ammonia, anhydrous lactose, ferrosoferric oxide, gelatin, lactose monohydrate, magnesium stearate, microcrystalline cellulose, propylene glycol, shellac, titanium dioxide, FD&C Red No. 3, FD&C Blue No. 1, FD&C Red No. 40
Has lactose · Has dyes: FD&C Blue No. 1, FD&C Red No. 3, FD&C Red No. 40
Product page on granulespharma.com
1 mg White opaque cap and white opaque body, capsule, 18 mm, marked “GPI / 1mg / 084”
| Package | NDC |
|---|---|
| Bottle of 100 | 70010-084-01 |
| Bottle of 1000 | 70010-084-10 |
2 mg Pink opaque cap and white opaque body, capsule, 18 mm, marked “GPI / 2mg / 085”
| Package | NDC |
|---|---|
| Bottle of 100 | 70010-085-01 |
| Bottle of 1000 | 70010-085-10 |
5 mg DARK BLUE OPAQUE CAP AND WHITE OPAQUE BODY, capsule, 22 mm, marked “GPI / 5mg / 086”
| Package | NDC |
|---|---|
| Bottle of 100 | 70010-086-01 |
| Bottle of 250 | 70010-086-25 |
Inactive ingredients: ferrosoferric oxide, gelatin, lactose monohydrate, magnesium stearate, microcrystalline cellulose, propylene glycol, shellac, silicon dioxide, titanium dioxide, ammonia, anhydrous lactose, FD&C Red No. 3, FD&C Blue No. 1, FD&C Red No. 40
Has lactose · Has dyes: D&C Yellow No. 10, FD&C Green No. 3, D&C Red No. 28, FD&C Blue No. 1, FD&C Red No. 40
1 mg Dark green opaque and light brown opaque, capsule, 18 mm, marked “MYLAN / 1101”
| Package | NDC |
|---|---|
| Carton of 100 | 51079-630-20 |
2 mg Brown opaque and light brown opaque, capsule, 18 mm, marked “MYLAN / 2302”
| Package | NDC |
|---|---|
| Carton of 100 | 51079-631-20 |
5 mg Light blue opaque and light brown opaque, capsule, 21 mm, marked “MYLAN / 3205”
| Package | NDC |
|---|---|
| Carton of 100 | 51079-632-20 |
Inactive ingredients: silicon dioxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, ferrosoferric oxide, gelatin, ferric oxide red, titanium dioxide, ferric oxide yellow, D&C Yellow No. 10, FD&C Green No. 3, ammonia, propylene glycol, shellac, dimethicone, D&C Red No. 28, FD&C Blue No. 1, FD&C Red No. 40
Has lactose · Has dyes: D&C Yellow No. 10, FD&C Green No. 3, D&C Red No. 28, FD&C Blue No. 1, FD&C Red No. 40
1 mg Dark green opaque and light brown opaque, capsule, 18 mm, marked “MYLAN / 1101”
| Package | NDC |
|---|---|
| Bottle of 100 | 0378-1101-01 |
| Bottle of 1000 | 0378-1101-10 |
2 mg Brown opaque and light brown opaque, capsule, 18 mm, marked “MYLAN / 2302”
| Package | NDC |
|---|---|
| Bottle of 100 | 0378-2302-01 |
| Bottle of 1000 | 0378-2302-10 |
5 mg Light blue opaque and light brown opaque, capsule, 21 mm, marked “MYLAN / 3205”
| Package | NDC |
|---|---|
| Bottle of 100 | 0378-3205-01 |
| Bottle of 250 | 0378-3205-25 |
Inactive ingredients: silicon dioxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, ferrosoferric oxide, gelatin, ferric oxide red, titanium dioxide, ferric oxide yellow, D&C Yellow No. 10, FD&C Green No. 3, ammonia, propylene glycol, shellac, dimethicone, D&C Red No. 28, FD&C Blue No. 1, FD&C Red No. 40
Has lactose · Made by MSN Laboratories
Product page on novadozpharma.com
1 mg White, capsule, 18 mm, marked “MP15”
| Package | NDC |
|---|---|
| Bottle of 90 | 72205-275-90 |
| Bottle of 100 | 72205-275-91 |
| Bottle of 250 | 72205-275-95 |
| Bottle of 1000 | 72205-275-99 |
2 mg Pink and white, capsule, 18 mm, marked “MP14”
| Package | NDC |
|---|---|
| Bottle of 100 | 72205-276-91 |
| Bottle of 250 | 72205-276-95 |
| Bottle of 1000 | 72205-276-99 |
5 mg Blue and white, capsule, 18 mm, marked “MP13”
| Package | NDC |
|---|---|
| Bottle of 100 | 72205-277-91 |
| Bottle of 250 | 72205-277-95 |
| Bottle of 1000 | 72205-277-99 |
Inactive ingredients: silicon dioxide, lactose monohydrate, starch, corn, magnesium stearate, sodium lauryl sulfate, sodium starch glycolate type a potato, titanium dioxide, gelatin, ferrosoferric oxide, propylene glycol, potassium hydroxide, shellac
Has lactose · Has dyes: D&C Yellow No. 10, D&C Yellow No. 10 aluminum lake, FD&C Blue No. 1 aluminum lake, FD&C Blue No. 2 aluminum lake, FD&C Red No. 40 aluminum lake, D&C Red No. 28, FD&C Blue No. 1, FD&C Red No. 40
1 mg Ivory, capsule, 18 mm, marked “TEVA / 4067”
| Package | NDC |
|---|---|
| Bottle of 100 | 0093-4067-01 |
| Bottle of 1000 | 0093-4067-10 |
2 mg Pink, capsule, 18 mm, marked “TEVA / 4068”
| Package | NDC |
|---|---|
| Bottle of 100 | 0093-4068-01 |
| Bottle of 1000 | 0093-4068-10 |
5 mg Light blue, capsule, 22 mm, marked “TEVA / 4069”
| Package | NDC |
|---|---|
| Bottle of 100 | 0093-4069-01 |
| Bottle of 250 | 0093-4069-52 |
| Bottle of 500 | 0093-4069-05 |
Inactive ingredients: anhydrous lactose, D&C Yellow No. 10, D&C Yellow No. 10 aluminum lake, FD&C Blue No. 1 aluminum lake, FD&C Blue No. 2 aluminum lake, FD&C Red No. 40 aluminum lake, ferrosoferric oxide, magnesium stearate, n-butyl alcohol, propylene glycol, shellac, starch, corn, titanium dioxide, D&C Red No. 28, FD&C Red No. 40, FD&C Blue No. 1, ammonia, dimethicone 350, silica, trimethylsilyl capped
Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.
Prazosin hydrochloride capsules are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including this drug.
Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program's Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).
Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly.
Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal.
Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy.
Prazosin hydrochloride capsules can be used alone or in combination with other antihypertensive drugs such as diuretics or beta-adrenergic blocking agents.
Source: the FDA label for Prazosin Hydrochloride (Prasco Laboratories), March 6, 2026. Full label on DailyMed
Prices checked November 17, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/minipress/